dr. tolaney discusses neratinib in her2 breast cancer
Published 6 years ago • 570 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
1:39
dr. tolaney on novel approaches in treating her2-positive breast cancer
-
2:06
dr. tolaney on deescalating therapy in stage i her2 breast cancer
-
1:55
dr. tolaney on abemaciclib plus pembrolizumab for hr , her2- breast cancer
-
1:32
dr. tolaney on the evolution of treatment in her2 breast cancer
-
0:49
dr. tolaney on the current treatment landscape for her2 breast cancer
-
1:25
dr. tolaney on the neoadjuvant therapy for her2-positive breast cancer
-
1:39
dr. tolaney on sequencing strategies in metastatic her2 breast cancer
-
1:08
dr. tolaney discusses the role of chemotherapy in her2 breast cancer
-
9:35
neratinib in her2 breast cancer
-
1:24
dr. tolaney discusses pertuzumab in her2 breast cancer
-
1:44
dr. tolaney on the atempt trial for her2 breast cancer
-
1:41
dr. tolaney on activity with abemaciclib in patients with hr /her2– breast cancer
-
2:18
use of neratinib in her2-positive breast cancer
-
1:48
dr. tolaney on the evolution of adjuvant treatment for her2 breast cancer
-
1:00
dr. tolaney on remaining questions with cdk4/6 inhibitors in hr /her2- breast cancer
-
1:20
dr. tripathy discusses neratinib in her2 breast cancer
-
1:38
dr. tolaney on cns recurrence in her2 breast cancer
-
4:09
her2 breast cancer: neratinib patient selection
-
1:41
dr. traina discusses neratinib in her2 breast cancer